| pubmed-article:7876722 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7876722 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:7876722 | lifeskim:mentions | umls-concept:C0035322 | lld:lifeskim |
| pubmed-article:7876722 | lifeskim:mentions | umls-concept:C0032580 | lld:lifeskim |
| pubmed-article:7876722 | lifeskim:mentions | umls-concept:C0220908 | lld:lifeskim |
| pubmed-article:7876722 | lifeskim:mentions | umls-concept:C0332887 | lld:lifeskim |
| pubmed-article:7876722 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:7876722 | pubmed:dateCreated | 1995-4-6 | lld:pubmed |
| pubmed-article:7876722 | pubmed:abstractText | Retinal examination by indirect ophthalmoscopy was performed on seventy members from 20 kindreds demonstrating the clinical manifestations of familial adenomatous polyposis and forty controls. Thirty-four of 43 affected patients manifested CHRPE lesions compared with 2 of 27 at risk and 2 of 40 controls giving a sensitivity of 79% and specificity of 95% based on the control group. The difference between the affected and at risk groups was significant (Chi-squared = 34.098, 1 df, P = 0.001). The low sensitivity and variation in incidence of CHRPE in FAP patients and general population documented in the world literature prevent its use as a sole marker for the condition. With advances in knowledge of the disease at a molecular level it is now possible to alter risks for families by DNA analysis. There remain a number of patients in whom such techniques do not significantly alter risks. In these families by combining the results of DNA analysis, sigmoidoscopy and retinal examination it may be possible to alter risks by a significant degree. Retinal examination should be reserved for those families in whom risks cannot be altered sufficiently by DNA analysis alone. | lld:pubmed |
| pubmed-article:7876722 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7876722 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7876722 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7876722 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7876722 | pubmed:issn | 0179-1958 | lld:pubmed |
| pubmed-article:7876722 | pubmed:author | pubmed-author:ParksT GTG | lld:pubmed |
| pubmed-article:7876722 | pubmed:author | pubmed-author:CampbellW JWJ | lld:pubmed |
| pubmed-article:7876722 | pubmed:author | pubmed-author:SpenceR ARA | lld:pubmed |
| pubmed-article:7876722 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7876722 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:7876722 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7876722 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7876722 | pubmed:pagination | 191-6 | lld:pubmed |
| pubmed-article:7876722 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:7876722 | pubmed:meshHeading | pubmed-meshheading:7876722-... | lld:pubmed |
| pubmed-article:7876722 | pubmed:meshHeading | pubmed-meshheading:7876722-... | lld:pubmed |
| pubmed-article:7876722 | pubmed:meshHeading | pubmed-meshheading:7876722-... | lld:pubmed |
| pubmed-article:7876722 | pubmed:meshHeading | pubmed-meshheading:7876722-... | lld:pubmed |
| pubmed-article:7876722 | pubmed:meshHeading | pubmed-meshheading:7876722-... | lld:pubmed |
| pubmed-article:7876722 | pubmed:meshHeading | pubmed-meshheading:7876722-... | lld:pubmed |
| pubmed-article:7876722 | pubmed:meshHeading | pubmed-meshheading:7876722-... | lld:pubmed |
| pubmed-article:7876722 | pubmed:meshHeading | pubmed-meshheading:7876722-... | lld:pubmed |
| pubmed-article:7876722 | pubmed:meshHeading | pubmed-meshheading:7876722-... | lld:pubmed |
| pubmed-article:7876722 | pubmed:meshHeading | pubmed-meshheading:7876722-... | lld:pubmed |
| pubmed-article:7876722 | pubmed:meshHeading | pubmed-meshheading:7876722-... | lld:pubmed |
| pubmed-article:7876722 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7876722 | pubmed:articleTitle | The role of congenital hypertrophy of the retinal pigment epithelium in screening for familial adenomatous polyposis. | lld:pubmed |
| pubmed-article:7876722 | pubmed:affiliation | Department of Surgery, Belfast City Hospital, UK. | lld:pubmed |
| pubmed-article:7876722 | pubmed:publicationType | Journal Article | lld:pubmed |
